Clinical Trials Browser

Completed × Adenocarcinoma × rilotumumab × Clear all

NCT01443065 2020-11-17

MEGA

Phase 2 Completed

Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms